9th - 10th September, Cambridge, UK
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThe Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled “Q9(R1) Quality Risk Management.”
A write up of the event by Graham Carroll
The E6(R3) overarching principles, Annex 1, Glossary and 3 Appendices will replace the current E6(R2). These are anticipated to reach Step 2 soon and will be available for public consultation.
The government intends to introduce regulations in future that will implement a substantial reform of the current regulatory framework for medical devices in the UK.
The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to making transparency and accountability to the public a fundamental principle of how we do business.
Shiva Ramroop, discusses how we ensure the safety of vaccines for children in the UK.
Clarification of the requirements for the submission of audit reports
Held on 21-22 February 2023 - here is write up of the event.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 18-20 April 2023